wondered why pps was climbing -nothing on otc to indicate a

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Plus Therapeutics Showcases Clinical Advances in REYOBIQ™ Houston-based Plus Therapeutics, Inc. (NASDAQ: PSTV) recently presented its promising results from the ReSPECT-LM clinical trial, specifically focusing on the treatment of patients with leptomeningeal metastases (LM). This presentation was made by the trial's principal investigator during the notable SNO/ASCO CNS...

Domo Earnings Report Overview Domo (NASDAQ: DOMO) is preparing to announce its quarterly earnings, and anticipation is building among investors. This release is particularly significant as the market eagerly awaits insights into the company’s fiscal health and future guidance. What Analysts Expect Analysts predict that Domo will report an earnings per share (EPS) of...

Understanding Recent Trends in Haleon PLC Stock Haleon PLC (NYSE: HLN) has recently seen a notable increase in its short interest, which has grown by 10.34% since the last report. Currently, there are approximately 14.34 million shares sold short, comprising around 0.32% of all the available shares for trading. The Significance of Short Interest But what does this short...

Examining the Effects of Political Promises on Energy Prices As the upcoming election approaches, politicians are making strong promises focused on energy. Former President Donald Trump is pushing for a "drill, baby, drill" strategy to help reduce energy prices, while Vice President Kamala Harris is prioritizing her commitment to fracking. Looking Ahead: Energy Trends...

First Watch Appoints Rob Conti as Chief Information Officer First Watch Restaurant Group, Inc. (NASDAQ: FWRG), a prominent name in daytime dining, has made a notable leadership change by promoting Rob Conti to the position of Chief Information Officer. Since joining the company in 2019, Conti has been a vital part of the team, having previously held the role of Senior...